1
|
Gerunova LK, Gerunov TV, P'yanova LG, Lavrenov AV, Sedanova AV, Delyagina MS, Fedorov YN, Kornienko NV, Kryuchek YO, Tarasenko AA. Butyric acid and prospects for creation of new medicines based on its derivatives: a literature review. J Vet Sci 2024; 25:e23. [PMID: 38568825 PMCID: PMC10990906 DOI: 10.4142/jvs.23230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 01/19/2024] [Accepted: 01/22/2024] [Indexed: 04/05/2024] Open
Abstract
The widespread use of antimicrobials causes antibiotic resistance in bacteria. The use of butyric acid and its derivatives is an alternative tactic. This review summarizes the literature on the role of butyric acid in the body and provides further prospects for the clinical use of its derivatives and delivery methods to the animal body. Thus far, there is evidence confirming the vital role of butyric acid in the body and the effectiveness of its derivatives when used as animal medicines and growth stimulants. Butyric acid salts stimulate immunomodulatory activity by reducing microbial colonization of the intestine and suppressing inflammation. Extraintestinal effects occur against the background of hemoglobinopathy, hypercholesterolemia, insulin resistance, and cerebral ischemia. Butyric acid derivatives inhibit histone deacetylase. Aberrant histone deacetylase activity is associated with the development of certain types of cancer in humans. Feed additives containing butyric acid salts or tributyrin are used widely in animal husbandry. They improve the functional status of the intestine and accelerate animal growth and development. On the other hand, high concentrations of butyric acid stimulate the apoptosis of epithelial cells and disrupt the intestinal barrier function. This review highlights the biological activity and the mechanism of action of butyric acid, its salts, and esters, revealing their role in the treatment of various animal and human diseases. This paper also discussed the possibility of using butyric acid and its derivatives as surface modifiers of enterosorbents to obtain new drugs with bifunctional action.
Collapse
Affiliation(s)
- Lyudmila K Gerunova
- Department of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation
| | - Taras V Gerunov
- Department of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation
| | - Lydia G P'yanova
- Department of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation
| | - Alexander V Lavrenov
- Department of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation
| | - Anna V Sedanova
- Department of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation
| | - Maria S Delyagina
- Department of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation.
| | - Yuri N Fedorov
- Laboratory of Immunology, All-Russian Research and Technological Institute of Biological Industry, pos. Biokombinata, Shchelkovskii Region, Moscow Province 141142, Russian Federation
| | - Natalia V Kornienko
- Department of Materials Science and Physicochemical Research Methods, Center of New Chemical Technologies BIC, Omsk 644040, Russian Federation
| | - Yana O Kryuchek
- Department of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation
| | - Anna A Tarasenko
- Department of Pharmacology and Toxicology, Omsk State Agrarian University named after P. A. Stolypin, Omsk 644008, Russian Federation
| |
Collapse
|
2
|
Physicochemical approach for the modification of medical nanoporous carbon sorbents. ADSORPTION 2023. [DOI: 10.1007/s10450-023-00378-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
|
3
|
Getsina M, P'yanova L, Kornienko N, Lavrenov A, Ershov A, Beloborodova N. Applicability of modified carbon sorbent for removing potentially toxic biologically active molecules of aromatic structure from blood plasma. Int J Artif Organs 2021; 44:930-937. [PMID: 34137293 DOI: 10.1177/03913988211018478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The modification of the mesoporous carbon sorbent with 3-phenylpropanoic acid was carried out in order to create preparations of complex, prolonged action, exhibiting detoxifying, antibacterial, and antifungal properties due to the applied modifier, which is capable of migrating into the solution and exhibiting its own biospecific properties. A technique was developed for fixing 3-phenylpropionic acid (PhPA) on a carbon support by its adsorption from solution. Three types of sorbents with various content of the modifier (PhPA) and the sorbent without modifier were studied. The sorption activity of new sorbents was studied using liquid-liquid extraction and gas chromatography-mass spectrometry methods on model experiments with plasma and aqueous additives of hydroxylated phenyl-containing acids (PhCAs) in various concentrations. The specific surface area was significantly changed for sorbent, modified with 1 × 10-3 mol/L of PhPA solution, and was 25% less than the area of unmodified sorbent. Potentially toxic biologically active hydroxylated PhCAs were used to create model solutions. The degrees of sorption of these compounds were close to 100%, except phenyllactic acid (over 80%). The sorbent without modifier and two sorbents with the lowest content of the modifier are considered to be more effective for the purification of the plasma from the hydroxylated PhCAs than the sorbent with the highest concentration of the modifier. Simultaneous adsorption of toxic metabolites from the bloodstream and desorption of beneficial ones can be used for a more subtle correction of the patient's condition.
Collapse
Affiliation(s)
- Maria Getsina
- Laboratory of Human Metabolism in Critical States, Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russian Federation
| | - Lidia P'yanova
- Center of New Chemical Technologies of the Federal Research Center Boreskov Institute of Catalysis of Siberian Branch of the Russian Academy of Sciences, Omsk, Russian Federation
| | - Natalia Kornienko
- Center of New Chemical Technologies of the Federal Research Center Boreskov Institute of Catalysis of Siberian Branch of the Russian Academy of Sciences, Omsk, Russian Federation
| | - Alexander Lavrenov
- Center of New Chemical Technologies of the Federal Research Center Boreskov Institute of Catalysis of Siberian Branch of the Russian Academy of Sciences, Omsk, Russian Federation
| | - Anton Ershov
- Laboratory of Human Metabolism in Critical States, Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russian Federation
| | - Natalia Beloborodova
- Laboratory of Human Metabolism in Critical States, Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russian Federation
| |
Collapse
|